Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Steatohepatitis
1
Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease
9/15/2022 1:37:25 PM |
Browse: 248 |
Download: 499
2
Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
9/13/2022 3:28:02 AM |
Browse: 317 |
Download: 697
3
Hereditary fructose intolerance: A comprehensive review
7/6/2022 1:21:32 PM |
Browse: 290 |
Download: 484
4
Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
12/27/2021 5:24:00 AM |
Browse: 350 |
Download: 610
5
Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
8/10/2021 6:48:42 AM |
Browse: 372 |
Download: 564
6
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
9/9/2020 11:11:52 AM |
Browse: 508 |
Download: 1202
7
Alcoholic liver disease: Utility of animal models
12/7/2018 3:57:11 AM |
Browse: 1009 |
Download: 1472
8
Non-alcoholic fatty liver disease: An expanded review
6/6/2017 12:54:56 AM |
Browse: 1396 |
Download: 1271
9
Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
4/20/2017 3:58:56 PM |
Browse: 1455 |
Download: 2280
10
Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
2/27/2017 8:50:00 AM |
Browse: 1179 |
Download: 1558
11
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM |
Browse: 1204 |
Download: 1532
12
Iron and non-alcoholic fatty liver disease
9/26/2016 8:04:00 AM |
Browse: 1169 |
Download: 1326
13
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
9/14/2016 7:04:00 PM |
Browse: 1267 |
Download: 2227
14
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model
8/3/2016 8:11:00 AM |
Browse: 998 |
Download: 1856
15
Host factors are dominant in the development of post-liver transplant non-alcoholic steatohepatitis
5/19/2016 3:13:00 PM |
Browse: 998 |
Download: 1261
16
Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease
4/19/2016 9:45:00 AM |
Browse: 1013 |
Download: 1756
17
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver
1/26/2016 6:22:00 PM |
Browse: 1358 |
Download: 2013
18
Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?
12/10/2015 10:35:00 AM |
Browse: 1210 |
Download: 1339
19
Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis
9/7/2015 4:31:00 PM |
Browse: 1147 |
Download: 1962
20
Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease
7/14/2015 12:17:00 PM |
Browse: 1174 |
Download: 2257
21
Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries
5/20/2015 4:43:00 PM |
Browse: 1041 |
Download: 1236
22
Role of vitamins in gastrointestinal diseases
5/13/2015 10:38:00 AM |
Browse: 1155 |
Download: 1670
23
Vitamin D: A new player in non-alcoholic fatty liver disease?
2/11/2015 5:56:00 PM |
Browse: 1161 |
Download: 1173
24
Red cell distribution width and nonalcoholic steatohepatitis
12/5/2014 11:43:00 AM |
Browse: 935 |
Download: 1031
25
Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?
12/2/2014 10:47:00 AM |
Browse: 1475 |
Download: 1474
26
Liver transplantation and non-alcoholic fatty liver disease
11/17/2014 3:13:00 PM |
Browse: 1151 |
Download: 1096
27
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
9/18/2014 7:49:00 PM |
Browse: 1646 |
Download: 1417
28
Dipeptidyl peptidase-4: A key player in chronic liver disease
9/16/2014 1:19:00 PM |
Browse: 1211 |
Download: 1094
29
Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats
9/16/2014 11:44:00 AM |
Browse: 1079 |
Download: 962
30
Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease
9/10/2014 4:40:00 PM |
Browse: 1082 |
Download: 716
31
Clinical approaches to non-alcoholic fatty liver disease
9/2/2014 5:02:00 PM |
Browse: 1138 |
Download: 704
32
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen
8/26/2014 2:46:00 PM |
Browse: 1208 |
Download: 1156
33
Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: A controversial issue
8/26/2014 2:46:00 PM |
Browse: 943 |
Download: 755
34
Fibrogenesis in alcoholic liver disease
8/26/2014 11:43:00 AM |
Browse: 1012 |
Download: 929
Page 1 of 1 ( 34 items )
<<
1
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345